Core Viewpoint - The company Jimin Health (603222) has announced a forecast for a net loss of 210 million to 250 million yuan for the year 2025, compared to a loss of 59.71 million yuan in the previous year [4] Financial Performance - The expected net profit loss for 2025 is between 210 million and 250 million yuan, with a non-recurring net profit loss estimated at 205 million to 245 million yuan, compared to a loss of 58.69 million yuan in the previous year [4] - The company's price-to-book ratio (LF) is approximately 3.55 times, and the price-to-sales ratio (TTM) is about 7.78 times based on the latest closing price [4] Business Impact Factors - The company's revenue has declined further due to factors such as U.S. tariff policies and the "He Qinghong stamp forgery incident," leading to increased losses [15] - The company has made provisions for inventory impairment of approximately 37 million yuan for pre-filled catheter flushing devices and safety syringes [15] - Losses related to the "He Qinghong and others forging company seals" case have been confirmed at around 38 million yuan [15] - The performance of Ezhou Second Hospital has declined compared to the previous year, prompting the company to make a goodwill impairment provision of approximately 20 million yuan [15]

Core Viewpoint - The company is forecasting a net loss for 2025, with expected losses ranging from 2.6 million to 3.9 million yuan, a significant decline from a profit of 36.12 million yuan in the previous year [4]. Financial Performance - The company anticipates a non-recurring net profit loss between 11 million and 16 million yuan, compared to a profit of 25.56 million yuan in the same period last year [4]. - The latest closing price indicates a price-to-book ratio (LF) of approximately 5.38 times and a price-to-sales ratio (TTM) of about 14.57 times [4]. Business Operations - The company specializes in network intelligence and information security solutions, including hardware and software [15]. - The gross profit margin is around 60%, which has increased compared to the previous year, but the operating revenue has declined due to reduced capital expenditures from operators [15]. - The company is in the process of expanding its new subsidiaries, which have not yet contributed to profits [15]. - There has been an increase in interest expenses due to the issuance of convertible bonds in 2025, alongside increased R&D expenditures [15]. Market Expansion - The company is actively expanding in AI solutions, large network security, vehicle networking security, and overseas markets, achieving some success [16]. - The order backlog has increased compared to the previous year, indicating a healthy demand for the company's services [16].

中证智能财讯永创智能（603901）1月23日晚间披露2025年度业绩预告，预计2025年归母净利润1.28亿元至1.55亿元，同比增长721.57%-894.86%；扣非净利 润预计1.2亿元至1.47亿元，同比增长6817.95%-8374.49%。以1月23日收盘价计算，永创智能目前市盈率（TTM）约为50.33倍-60.95倍，市净率（LF）约3.18 倍，市销率（TTM）约1.93倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况 (倍) 300 @00 100 45662 26.88 42898 31845 24928 24878 24065 0 -100 -200 -300 2022-06-30 : 2021-06-30 2021-12-37 J-12-37 22-12-37 4-06-30 3-12-37 2n- -○- 公司 -○- 行业均值 制图数据来自恒生聚源数据库 市净率(LF)历史分位(%) 100 ହି ୨୦ 84-33 80 70 6673 60 50-71 50 43.5 40 37605 30 20 -18-56 10 3.32 0 ...

中证智能财讯格尔软件（603232）1月23日晚间披露2025年度业绩预告，预计2025年归母净利润亏损6000万元至9000万元，上年同期盈利3681.21万元；扣非 净利润亏损8000万元至1.2亿元，上年同期盈利1569.42万元。以最新收盘价计算，市净率（LF）约4.12倍，市销率（TTM）约12.84倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况（倍） 800 708.39 9600 609 + 400 200 123.49 89.66 67.83 54.89 64812 55,93 0 -200 2021-12-37 2020-12-37 2022-06-30 2021-06-30 2022-12-37 3-06-30 3-72-3- 2n- -○- 公司 -○- 行业均值 100 93-4 ହି ୨୦ 80 70 60 50 48871 4689 40 37661 30 20 10 0 2027-12-37 I 2020-12-37 1 2022-72-37 1 2021-06-30 1 3-12-37 . 3-06-30 2022-06-30 ' ...

中证智能财讯华脉科技（603042）1月23日晚间披露2025年度业绩预告，预计2025年归母净利润亏损5800万元至7200万元，上年同期盈利1456.95万元；扣非 净利润亏损6800万元至8200万元，上年同期亏损1071.24万元。以最新收盘价计算，市净率（LF）约3.24倍，市销率（TTM）约3.19倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况 (倍) 800 -778.33 ড্রি00 400 200 58:25 79 63 44-59 0 -720 -200 -400 2022-06-30 2021-12-37 2021-06-30 ' 2022-12-37 2020-12-37 -3-06-30 23-12-3- 2n- -○- 公司 -○- 行业均值 100 984 ହ 90 80 70 60 60 43 50 45.25 40 30 20 15.88 10 0 2027-12-37 | 2021-06-30 | 2020-12-37 I 4-06-30 3-06-30 1 2022-06-30 | 2022-12-37 | 023-12-3 ...

中证智能财讯拱东医疗（605369）1月23日晚间披露2025年度业绩预告，预计2025年归母净利润4400万元至5600万元，同比下降67.37%-74.36%；扣非净利润 预计5400万元-6600万元，同比下降60.75%-67.89%。以1月23日收盘价计算，拱东医疗目前市盈率（TTM）约为77.37倍-98.47倍，市净率（LF）约2.52倍， 市销率（TTM）约3.85倍。 ） 制图数据来自恒生聚源数据库 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况 (倍) 100 @ 80 60 29-39 50.6 45x79 40 42082 32-37 3 588 2422 20 0 2021-06-30 | 2027-12-37 1 2022-12-37 1 2020-12-37 ' 023-12-37 ' 4-06-30 2022-06-30 | 023-06-30 ' 2n- -○- 公司 -○- 行业均值 100 970 94a4 ହ 90 83 - 8 80 76072 70 60 50 40 40.4 30 20 10 7.32 7.56 0 2020 ...

Group 1 - The company, Nongfa Seed Industry (600313), forecasts a net profit attributable to shareholders of 75 million to 84 million yuan for 2025, representing a year-on-year increase of 59.96% to 79.15% [2] - The company expects a non-recurring net profit of 19.19 million to 28.19 million yuan, recovering from a loss of 27.516 million yuan in the same period last year [2] - As of January 23, the company's price-to-earnings ratio (TTM) is approximately 87.35 to 97.83 times, with a price-to-book ratio (LF) of about 3.72 times and a price-to-sales ratio (TTM) of about 1.18 times [2] Group 2 - The company's main business includes the research, production, and sales of crop seeds, production and sales of pesticide products, fertilizer trading, and specialty grain order business [6] - The increase in performance is attributed to several factors: expansion of sales channels in the seed business, significant growth in revenue and profit in the fertilizer business due to active sourcing of imports, and improved market share in the pesticide business through enhanced production processes and cost reduction measures [6]

Core Viewpoint - The company Shandong Huawutang Cosmetics Co., Ltd., the parent company of Banmu Huatian, has submitted an application for listing on the Hong Kong Stock Exchange, with CITIC Securities acting as the sole sponsor [1]. Group 1: Business Strategy and Product Development - Banmu Huatian has expanded from a single product strategy to a full-category approach, launching facial and hair care products alongside its core body scrub, which has sold 37.7 million bottles as of September 30, 2025 [2]. - The company aims to enhance sustainable profitability by diversifying its product offerings, with a total of 509 main SKUs as of September 30, 2025 [2]. - The top-selling product on its Tmall flagship store is the amino acid cleansing mousse [2]. Group 2: Financial Performance - Banmu Huatian's revenue for the years 2023, 2024, and the first three quarters of 2025 was 1.199 billion, 1.499 billion, and 1.895 billion RMB, respectively, with adjusted net profits of 23.7 million, 82.8 million, and 148 million RMB [2][4]. - The company experienced a revenue growth of 76.7% and an adjusted net profit increase of 197.2% from the first three quarters of 2024 to the first three quarters of 2025 [2]. - The gross profit margins for 2023, 2024, and the first three quarters of 2025 were 65.8%, 62.3%, and 63.3%, respectively [3][4]. Group 3: Revenue Breakdown by Product Category - For the first three quarters of 2025, body care products contributed 791 million RMB, accounting for 41.8% of total revenue, while hair care and facial care products each contributed 482 million RMB and 463 million RMB, representing 25.4% of total revenue [3]. Group 4: Cost Structure and R&D Investment - Sales expenses for 2023, 2024, and the first three quarters of 2025 were 410 million, 566 million, and 695 million RMB, making up 34.2%, 37.7%, and 36.7% of revenue, respectively [5]. - The total R&D expenses from 2023 to the first three quarters of 2025 amounted to only 88.76 million RMB [6]. - The company primarily relies on outsourcing for manufacturing, using specific qualified OEM suppliers for skin and personal care products [7]. Group 5: Fundraising and Future Plans - The funds raised from the IPO will be used for channel development, product marketing, brand building, enhancing R&D capabilities, and general corporate purposes [7].

Group 1 - The company plans to acquire 100% equity of Zhongshan Dehua Chip Technology Co., Ltd. through a combination of share issuance and cash payment, and will issue shares to no more than 35 specific investors to raise matching funds [2] - The share issuance price for the asset purchase is set at 14.46 yuan per share, with the total amount of raised funds not exceeding 100% of the asset transaction price, which will be used for cash consideration, project construction, debt repayment, and working capital [2] - The transaction is expected to constitute a related party transaction due to the involvement of the controlling shareholder of the target company, who is a relative of the actual controller of the company [2] Group 2 - The target company specializes in compound semiconductor epitaxial wafers, chips, and power systems, providing comprehensive solutions across the entire industry chain from epitaxial materials to power systems [2] - The company focuses on renewable energy solutions, power station development and operation, and electricity distribution, with a concentration on wind power, photovoltaics, and energy storage [2] - This transaction is expected to expand the company's strategic development space in the energy sector, adding a high-barrier, high-growth business segment, optimizing the overall business structure, and enhancing competitiveness in the photovoltaic field through joint R&D in energy management systems [3]

Market Performance - The three major A-share indices collectively rose, with the Shanghai Composite Index up by 0.33%, the Shenzhen Component Index up by 0.79%, and the ChiNext Index up by 0.63% [1] - Small-cap stocks outperformed, with the North Securities 50 Index rising by 3.82%, the CSI 500 Index up by 2.42%, and the CSI 1000 Index up by 1.94% [1] Solar Energy Sector - The solar energy sector surged due to news related to space photovoltaic technology, with over 30 stocks including Junda Co., Ltd. and GCL-Poly Energy Holdings Ltd. hitting the daily limit [3] - Longi Green Energy Technology Co., Ltd. saw a significant increase, closing at 19.35 yuan per share with a trading volume of 9.394 billion yuan and a total market capitalization of 146.6 billion yuan [3][4] Commercial Aerospace Sector - The commercial aerospace sector experienced a substantial rise, with stocks like Goldwind Science & Technology Co., Ltd. and Runbei Aerospace Technology Co., Ltd. hitting the daily limit [5][6] - Recent catalysts for the commercial aerospace sector include the upcoming Beijing International Commercial Aerospace Exhibition and the launch of several platforms aimed at supporting the industry [9][10] Solid-State Battery Sector - The solid-state battery sector showed strong performance, with companies like Oke Technology Co., Ltd. and Shanghai Washba Co., Ltd. hitting the daily limit [11] - Recent developments include advancements in solid-state battery technology by major automotive manufacturers, with plans for mass production expected by 2030 [15][16]